{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:14:23Z","timestamp":1782224063936,"version":"3.54.5"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Kwarteng Lab"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.biopha.2020.110914","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T12:33:58Z","timestamp":1603197238000},"page":"110914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques"],"prefix":"10.1016","volume":"132","author":[{"given":"Alexander","family":"Kwarteng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer","family":"Asiedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Amoah","family":"Sakyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Opoku","family":"Asiedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2020.110914_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/v12020135","article-title":"Return of the coronavirus: 2019-nCoV","volume":"12","author":"Gralinski","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2020.110914_bib0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the Novel Coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2020.110914_bib0015","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach","volume":"165878","author":"Naqvi","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Mol. Basis of Dis."},{"key":"10.1016\/j.biopha.2020.110914_bib0020","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan","volume":"323","author":"Wang","year":"2020","journal-title":"China, JAMA"},{"issue":"10223","key":"10.1016\/j.biopha.2020.110914_bib0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2020.110914_bib0030","article-title":"Clinical, molecular and epidemiological characterization of the SARS-CoV2 virus and the Coronavirus disease 2019 (COVID-19), a comprehensive literature review","volume":"115094","author":"Ortiz-Prado","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.biopha.2020.110914_bib0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","volume":"64","author":"Masters","year":"2006","journal-title":"Adv. Virus Res."},{"issue":"3","key":"10.1016\/j.biopha.2020.110914_bib0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10930-020-09901-4","article-title":"The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19","volume":"39","author":"Yoshimoto","year":"2020","journal-title":"Protein J."},{"key":"10.1016\/j.biopha.2020.110914_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0065-3527(05)64006-7","article-title":"Molecular interactions in the assembly of coronaviruses","volume":"64","author":"De Haan","year":"2005","journal-title":"Adv. Virus Res."},{"issue":"8","key":"10.1016\/j.biopha.2020.110914_bib0050","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"M. Van Zyl, B. Fielding, the coronavirus nucleocapsid is a multifunctional protein","volume":"6","author":"McBride","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2020.110914_bib0055","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1128\/JVI.72.8.6838-6850.1998","article-title":"Coronavirus particle assembly: primary structure requirements of the membrane protein","volume":"72","author":"De Haan","year":"1998","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.biopha.2020.110914_bib0060","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1128\/JVI.79.17.11476-11486.2005","article-title":"The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation","volume":"79","author":"Surjit","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2020.110914_bib0065","series-title":"Principles and Practice of Clinical Virology","first-page":"379","article-title":"Coronaviruses and toroviruses","author":"Cavanagh","year":"2004"},{"key":"10.1016\/j.biopha.2020.110914_bib0070","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1128\/JVI.73.9.7641-7657.1999","article-title":"Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication","volume":"73","author":"Van der Meer","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2020.110914_bib0075","article-title":"Drug repositioning an alternative for the treatment of coronavirus COVID-19","volume":"105969","author":"Serafin","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2020.110914_bib0080","series-title":"Draft of the Landscape of COVID-19 Candidate Vaccines","author":"World Health Organization","year":"2020"},{"issue":"2","key":"10.1016\/j.biopha.2020.110914_bib0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/vaccines4020012","article-title":"Recent advances in subunit vaccine carriers","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2020.110914_bib0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41541-020-0170-0","article-title":"The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines","volume":"5","author":"Shang","year":"2020","journal-title":"Npj Vaccines"},{"issue":"4","key":"10.1016\/j.biopha.2020.110914_bib0095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2020.110914_bib0100","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T cell responses to whole SARS coronavirus in humans","volume":"181","author":"Li","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2020.110914_bib0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2020.110914_bib0110","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2020.110914_bib0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2020.110914_bib0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"W1","key":"10.1016\/j.biopha.2020.110914_bib0125","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110914_bib0130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"10.1016\/j.biopha.2020.110914_bib0135","doi-asserted-by":"crossref","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2020.110914_bib0140","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2\u2014a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"issue":"1","key":"10.1016\/j.biopha.2020.110914_bib0145","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"issue":"W1","key":"10.1016\/j.biopha.2020.110914_bib0150","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkw329","article-title":"PEP-FOLD3: fasterde novostructure prediction for linear peptides in solution and in complex","volume":"44","author":"Lamiable","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biopha.2020.110914_bib0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2013protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"issue":"20","key":"10.1016\/j.biopha.2020.110914_bib0160","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/bioinformatics\/bts493","article-title":"Application of asymmetric statistical potentials to antibody-protein docking","volume":"28","author":"Brenke","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2020.110914_bib0165","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/prot.21117","article-title":"PIPER: an FFT-based protein docking program with pairwise potentials","volume":"65","author":"Kozakov","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.biopha.2020.110914_bib0170","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1073\/pnas.89.6.2195","article-title":"Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques","volume":"89","author":"Katchalski-Katzir","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biopha.2020.110914_bib0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"Charmm - a program for macromolecular energy, minimization, and dynamics calculations","volume":"4","author":"Brooks","year":"1983","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2020.110914_bib0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.biopha.2020.110914_bib0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0167-5699(92)90135-T","article-title":"A computer model of cellular interactions in the immune system","volume":"13","author":"Celada","year":"1992","journal-title":"Immunol. Today"},{"key":"10.1016\/j.biopha.2020.110914_bib0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-5193(05)80737-4","article-title":"A model for simulating cognate recognition and response in the immune system","volume":"158","author":"Seiden","year":"1992","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.biopha.2020.110914_bib0195","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/eji.1830260626","article-title":"Affinity maturation and hypermutation in a simulation of the humoral immune response","volume":"26","author":"Celada","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2020.110914_bib0200","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1084\/jem.157.4.1149","article-title":"The major histocompatibility complex-restricted antigen receptor on T cells","volume":"157","author":"Haskins","year":"1983","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2020.110914_bib0205","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0167-5699(93)90143-9","article-title":"The maturation of the immune response","volume":"14","author":"Bere","year":"1993","journal-title":"Immunol. Today"},{"key":"10.1016\/j.biopha.2020.110914_bib0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000313054","article-title":"The cellular basis of immunological memory","volume":"15","author":"Celada","year":"1971","journal-title":"Prog. Allergy"},{"key":"10.1016\/j.biopha.2020.110914_bib0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-065X.1988.tb00737.x","article-title":"T cell selection in the thymus","volume":"101","author":"Sprent","year":"1988","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2020.110914_bib0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0167-5699(87)90187-3","article-title":"Antigen processing at the molecular level","volume":"8","author":"Allen","year":"1987","journal-title":"Immunol. Today"},{"key":"10.1016\/j.biopha.2020.110914_bib0225","series-title":"T Cell Activation, Year in Immunology","first-page":"18","article-title":"The nature and role of antigen processing","author":"Berzofski","year":"1985"},{"key":"10.1016\/j.biopha.2020.110914_bib0230","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.iy.02.040184.002143","article-title":"Antigen-presenting function of the macrophage","volume":"2","author":"Unanue","year":"1985","journal-title":"Ann. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110914_bib0235","doi-asserted-by":"crossref","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2020.110914_bib0240","doi-asserted-by":"crossref","first-page":"e1298","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2020.110914_bib0245","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera?A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"16","key":"10.1016\/j.biopha.2020.110914_bib0250","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2020.110914_bib0255","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"T.E. Cheatham 3rd, calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"issue":"7","key":"10.1016\/j.biopha.2020.110914_bib0260","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.biopha.2020.110914_bib0265","article-title":"Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors","author":"Braun","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.biopha.2020.110914_bib0270","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/039463200501800312","article-title":"T-Cell response profiling to biological threat agents including the SARS coronavirus","volume":"18","author":"Gioia","year":"2005","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110914_bib0275","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01464-10","article-title":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein","volume":"84","author":"Liu","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2020.110914_bib0280","doi-asserted-by":"crossref","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS\u2010CoV\u20102 and mechanisms of immunopathological changes in COVID\u201019","author":"Azkur","year":"2020","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.biopha.2020.110914_bib0285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","volume":"10","author":"Li","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.biopha.2020.110914_bib0290","series-title":"Immunology of COVID-19: Current State of the Science, Immunity","author":"Vabret","year":"2020"},{"key":"10.1016\/j.biopha.2020.110914_bib0295","series-title":"., Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals, Immunity","author":"Ni","year":"2020"},{"key":"10.1016\/j.biopha.2020.110914_bib0300","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","author":"Xu","year":"2020","journal-title":"Lancet Resp. Med."},{"key":"10.1016\/j.biopha.2020.110914_bib0305","doi-asserted-by":"crossref","DOI":"10.1007\/s00705-009-0409-6","article-title":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection","volume":"154","author":"Fan","year":"2009","journal-title":"Arch. Virol."},{"key":"10.1016\/j.biopha.2020.110914_bib0310","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1743-422X-7-299","article-title":"Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients","volume":"7","author":"Cao","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.biopha.2020.110914_bib0315","doi-asserted-by":"crossref","first-page":"102763","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"Liu","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2020.110914_bib0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110914_bib0325","article-title":"Reinfection could not occur in SARS-CoV-2 infected rhesus macaques","author":"Bao","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.biopha.2020.110914_bib0330","article-title":"Evaluation of antibody testing for SARS-CoV-2 using ELISA and lateral flow immunoassays","author":"Adams","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.biopha.2020.110914_bib0335","article-title":"Structural and functional analysis of a potent sarbecovirus neutralizing antibody","author":"Pinto","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.110914_bib0340","article-title":"COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patient","author":"Song","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.biopha.2020.110914_bib0345","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biopha.2020.110914_bib0350","first-page":"3913e21","article-title":"Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein","volume":"81","author":"Saikatend","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2020.110914_bib0355","doi-asserted-by":"crossref","first-page":"4816e25","DOI":"10.1093\/nar\/gkl650","article-title":"Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells","volume":"34","author":"Tan","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.110914_bib0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2020.04.009","article-title":"Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites","author":"Kang","year":"2020","journal-title":"Acta. Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2020.110914_bib0365","article-title":"Nelfi- navir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro","author":"Yamamoto","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.110914_bib0370","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biopha.2020.110914_bib0375","doi-asserted-by":"crossref","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.biopha.2020.110914_bib0380","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biopha.2020.110914_bib0385","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1021\/bi036155b","article-title":"Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein","volume":"43","author":"Huang","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2020.110914_bib0390","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.str.2005.08.021","article-title":"The nucleocapsid protein of coronavirus infectious bronchitis virus: crystal structure of its N-terminal domain and multimerization properties","volume":"13","author":"Fan","year":"2005","journal-title":"Structure"},{"key":"10.1016\/j.biopha.2020.110914_bib0395","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1093\/nar\/gkl650","article-title":"Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells","volume":"34","author":"Tan","year":"2006","journal-title":"Nucleic Acids Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220311069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220311069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:14:27Z","timestamp":1760098467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220311069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":79,"alternative-id":["S0753332220311069"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110914","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110914"}}